Nontuberculous Mycobacterial Pulmonary Disease from Mycobacterium hassiacum, Austria

Emerg Infect Dis. 2020 Nov;26(11):2776-2778. doi: 10.3201/eid2611.191718.


The clinical relevance of newly described nontuberculous mycobacteria is often unclear. We report a case of pulmonary infection caused by Mycobacterium hassiacum in an immunocompetent patient in Austria who had chronic obstructive pulmonary disease. Antimicrobial drug susceptibility testing showed low MICs for macrolides, aminoglycosides, fluoroquinolones, tetracyclines, imipenem, and linezolid.

Keywords: 16S rRNA; Austria; Mycobacterium hassiacum; NTM-PD; antimycobacterials; bacteria; nontuberculous mycobacterial pulmonary disease; tuberculosis and other mycobacteria.

Publication types

  • Case Reports

MeSH terms

  • Austria
  • Humans
  • Lung Diseases* / diagnosis
  • Lung Diseases* / drug therapy
  • Lung Diseases* / microbiology
  • Microbial Sensitivity Tests
  • Mycobacteriaceae* / drug effects
  • Mycobacterium Infections, Nontuberculous* / diagnosis
  • Mycobacterium Infections, Nontuberculous* / drug therapy

Supplementary concepts

  • Mycolicibacterium hassiacum